CSIMarket
 
Biontech Se  (BNTX)
Other Ticker:  
 
 
Price: $92.4800 $-0.43 -0.463%
Day's High: $92.95 Week Perf: -3.97 %
Day's Low: $ 91.47 30 Day Perf: 1.12 %
Volume (M): 645 52 Wk High: $ 136.92
Volume (M$): $ 59,687 52 Wk Avg: $106.32
Open: $92.21 52 Wk Low: $87.90



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 1,700
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 10,567
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Biontech Se
Biontech SE is a German biotechnology company that focuses on developing immunotherapies for cancer and other medical conditions.
Founded in 2008 by husband-and-wife team Ugur Sahin and 'zlem T'reci, the company has its headquarters in Mainz, Germany, and operates research and development facilities in both the United States and Germany.
Biontech is primarily focused on the development of mRNA-based therapeutics, which involve the use of messenger RNA molecules to instruct cells to produce specific proteins or antibody molecules that can help fight various diseases.
As of 2021, Biontech is perhaps best known for its collaboration with Pfizer on the development of the BNT162b2 COVID-19 vaccine, which has been authorized for emergency use by regulatory agencies around the world.
The vaccine is based on mRNA technology, and has demonstrated high efficacy in clinical trials.
Biontech and Pfizer have also collaborated on the development of other potential mRNA-based therapies, including treatments for influenza and other infectious diseases.
Aside from its work on mRNA therapeutics, Biontech is also engaged in research into various types of cancer immunotherapies, including CAR-T cell therapies and checkpoint inhibitors.
The company has a number of clinical trials underway for these types of treatments, and has signed collaborations and licensing deals with a range of pharmaceutical companies.
Overall, Biontech is one of the leading biotechnology firms in Germany, with a reputation for innovation and a strong track record of success in developing cutting-edge therapies for a range of medical conditions.
The company employs hundreds of scientists and researchers, and is well-positioned to continue driving innovation in the field of immunotherapy and beyond.


   Company Address: An der Goldgrube 12 Mainz 0
   Company Phone Number: 6131-9084-0   Stock Exchange / Ticker: NASDAQ BNTX
   BNTX is expected to report next financial results on March 26, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Announcement

A Critical Deadline Looms for BioNTech SE Investors: Important Insights into the Securities Class Action

Published Sun, Mar 3 2024 8:14 PM UTC

In recent news, BioNTech SE (NASDAQ: BNTX), a prominent biotechnology company, finds itself embroiled in a securities class action lawsuit. The case, which spans from March 30, 2022, to October 13, 2023, has reached a crucial milestone with a lead plaintiff deadline of March 12, 2024. As the deadline approaches, investors and industry stakeholders must be aware of the implic...

Announcement

BioNTech SE Investors Urged to Seek Legal Counsel to Protect Their Rights Before March 12, 2024 Deadline

Published Fri, Jan 26 2024 6:20 PM UTC

In a recent announcement, Rosen Law Firm, a prominent global investor rights law firm, has advised investors who purchased securities of BioNTech SE (NASDAQ: BNTX) within the Class Period of March 30, 2022, to October 13, 2023, to secure legal counsel before the lead plaintiff deadline of March 12, 2024. This advisory is based on the ongoing securities class action against B...






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com